The Arkansas Insurance Department filed a June 17 motion asking the U.S. District Court for Eastern Arkansas to dismiss AstraZeneca’s claim that Arkansas’ 340B contract pharmacy access law is preempted by the federal 340B statute.
Higher Court Already Rejected AstraZeneca’s Claim on Arkansas 340B Contract Pharmacy Law, State Attorney Tells Federal Judge
Views
A key argument in AstraZeneca’s lawsuit challenging Arkansas’ 340B contract pharmacy access law has already been rejected by a higher [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
